KLK3 and benign prostatic hyperplasia: To take into account prostate volume, PSA density (PSAD) was introduced in the early 1990s by Benson et al. This was done in an attempt to improve the accuracy of serum PSA testing to distinguish between small-volume organ-confined PC and BPH [72].